Brief: Cumberland Pharmaceuticals Reports Q2 Adjusted EPS $0.10
14/08/2019 22:11
Aug 14 (Reuters) - Cumberland Pharmaceuticals Inc CPIX.O :
* CUMBERLAND PHARMACEUTICALS REPORTS 14% REVENUE GROWTH IN
THE
SECOND QUARTER
* Q2 ADJUSTED EARNINGS PER SHARE $0.10
* Q2 LOSS PER SHARE $0.04
* Q2 REVENUE ROSE 14 PERCENT TO $11.6 MILLION
Source text for Eikon: ID:nPn1Y2qjva
Further company coverage: CPIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cumberland Pharmaceuticals
See all newsBrief: Cumberland Pharmaceuticals Announces Assist-Ssc Trial Top-Line Results
Cumberland Pharmaceuticals Q2 loss widens after Apotex transaction
Brief: Cumberland Pharmaceuticals Announces Special Dividend Of $1.50 Per Share
Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDA‑approved brands to Apotex for $100 mln
NASDAQ RESUMED AT 09:38 AM